Anhui Anke Biotechnology (Group) Co (SZSE:300009) ROCE %: 15.80% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:300009 Anhui Anke Biotechnology (Group) Co Ltd SZSE:300009
90 GF Score
Price ¥8.82
GF Value ¥10.72
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Anhui Anke Biotechnology (Group) Co ROCE %?

Anhui Anke Biotechnology (Group) Co SZSE:300009 -1.45% 90 ROCE % is 15.80% as of Mar. 2026. GuruFocus rates SZSE:300009 with a GF Score™ of 90/100 and a GF Value™ of ¥10.72 (Modestly Undervalued). The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Anhui Anke Biotechnology (Group) Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 15.80%.

Anhui Anke Biotechnology (Group) Co  (SZSE:300009) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Anhui Anke Biotechnology (Group) Co ROCE % Related Terms

Anhui Anke Biotechnology (Group) Co ROCE % Historical Data

* Premium members only.

The historical data trend for Anhui Anke Biotechnology (Group) Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anhui Anke Biotechnology (Group) Co ROCE % Chart

Anhui Anke Biotechnology (Group) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.74 25.23 23.99 18.79 17.81

Anhui Anke Biotechnology (Group) Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.35 16.94 19.74 15.72 15.80
SZSE:300009
90GF Score
Anhui Anke Biotechnology (Group) Co Ltd SZSE:300009
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anhui Anke Biotechnology (Group) Co ROCE % Calculation

Anhui Anke Biotechnology (Group) Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=835.093/( ( (5135.35 - 667.585) + (5547.653 - 639.7) )/ 2 )
=835.093/( (4467.765+4907.953)/ 2 )
=835.093/4687.859
=17.81 %

Anhui Anke Biotechnology (Group) Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=788.964/( ( (5547.653 - 639.7) + (5664.605 - 583.545) )/ 2 )
=788.964/( ( 4907.953 + 5081.06 )/ 2 )
=788.964/4994.5065
=15.80 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 15.80% mean?
Anhui Anke Biotechnology (Group) Co (SZSE:300009) has a ROCE % of 15.80% as of Mar. 2026.
Is Anhui Anke Biotechnology (Group) Co's ROCE % too high?
Anhui Anke Biotechnology (Group) Co's current ROCE % is 15.80%. Overall, Anhui Anke Biotechnology (Group) Co has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Anhui Anke Biotechnology (Group) Co's ROCE % compare to VRTX and REGN?
Anhui Anke Biotechnology (Group) Co's ROCE % of 15.80% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Anhui Anke Biotechnology (Group) Co's current ROCE % is 15.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anhui Anke Biotechnology (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Anhui Anke Biotechnology (Group) Co (SZSE:300009) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥10.72, compared to a current price of ¥8.82 — trading 17.7% below its estimated fair value. The current ROCE % is 15.80%. Anhui Anke Biotechnology (Group) Co's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Anhui Anke Biotechnology (Group) Co (SZSE:300009), the current ROCE % is 15.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Anhui Anke Biotechnology (Group) Co (SZSE:300009) Overvalued in 2026?

Based on GuruFocus' analysis, Anhui Anke Biotechnology (Group) Co stock appears to be undervalued. The current stock price of ¥8.82 is trading 17.7% below its estimated GF Value™ of ¥10.72. GuruFocus considers Anhui Anke Biotechnology (Group) Co to be Modestly Undervalued.

Key valuation signals for SZSE:300009:

  • ROCE %: 15.80%
  • GF Value™: ¥10.72 vs. price of ¥8.82 (17.7% below fair value)
  • GF Score™: 90/100 with 1 warning sign

No single metric tells the full story. See the SZSE:300009 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Anhui Anke Biotechnology (Group) Co Business Description

Address No.9 Changjiang Road, Hefei High-tech Zone, Customs Road 669, Hefei, CHN, 230088
Anhui Anke Biotechnology (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceuticals and health-care products. The Company distributes its product in both domestic and overseas markets. The company operates in more than 30 provinces in China.
90GF Score

Get the complete analysis for SZSE:300009

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.82
Price
¥10.72
GF Value